<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00945763</url>
  </required_header>
  <id_info>
    <org_study_id>N1539-02</org_study_id>
    <nct_id>NCT00945763</nct_id>
  </id_info>
  <brief_title>Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery</brief_title>
  <official_title>A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Adaptive Design, Single-Dose Study of Intravenous N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alkermes, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alkermes, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and efficacy of single IV doses of N1539 after dental impaction
      surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, double-blind, placebo-controlled, single center study in subjects who
      have undergone third molar extraction surgery. Eligible subjects will have surgical removal
      of &gt;2 third molars, of which at least 1 must be a complete or partial mandibular impaction.
      Each subject's study participation will consist of a screening visit (1-21 days prior to
      surgery), an inpatient evaluation period of 24 hours following dosing, and a follow-up phone
      call 3-5 days postdose.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Intensity Difference at End of Study</measure>
    <time_frame>0-24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Onset of action</measure>
    <time_frame>0-1 hour</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">230</enrollment>
  <condition>Dental Pain</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>N1539 15 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>N1539 30 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>N1539 60 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Motrin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>N1539</intervention_name>
    <description>30 mg</description>
    <arm_group_label>N1539 30 mg</arm_group_label>
    <other_name>meloxicam</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>tablets</description>
    <arm_group_label>placebo</arm_group_label>
    <other_name>sugar pill</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>N1539</intervention_name>
    <description>15 mg</description>
    <arm_group_label>N1539 15 mg</arm_group_label>
    <other_name>meloxicam</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>N1539</intervention_name>
    <description>60 mg</description>
    <arm_group_label>N1539 60 mg</arm_group_label>
    <other_name>meloxicam</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Motrin</intervention_name>
    <description>400 mg</description>
    <arm_group_label>Motrin</arm_group_label>
    <other_name>ibuprofen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  surgical extraction of &gt; 2 third molars with at least 1 complete or partial mandibular
             bony extraction

        Exclusion Criteria:

          -  allergic response to aspirin, NSAIDs, acetaminophen or hydrocodone

          -  use of aspirin or other analgesics within 48 hours prior to surgery

          -  current or recent history of drug or alcohol abuse

          -  any medication for treatment of chronic pain

          -  clinically significant abnormality on screening laboratory test active or recent
             history of peptic ulcer disease or GI bleeding

          -  prior abdominal surgery, except uncomplicated appendectomy

          -  any other surgical procedure within 30 days before administration of study drug

          -  pregnancy or breastfeeding

          -  untreated hypertension; SBP &gt; 140 mmHg or DBP &gt; 95 mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Christensen, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jean Brown Research, Salt Lake City, UT 84124</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jean Brown Research</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.jeanbrownresearch.com</url>
    <description>Study site</description>
  </link>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2009</study_first_submitted>
  <study_first_submitted_qc>July 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2009</study_first_posted>
  <disposition_first_submitted>June 24, 2011</disposition_first_submitted>
  <disposition_first_submitted_qc>November 28, 2011</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">December 2, 2011</disposition_first_posted>
  <last_update_submitted>November 28, 2011</last_update_submitted>
  <last_update_submitted_qc>November 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dental Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Toothache</mesh_term>
    <mesh_term>Tooth, Impacted</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meloxicam</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

